RecruitingNot ApplicableNCT04375722
Transcranial Alternating Current Stimulation (tACS) in Aphasia
Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Aphasia
Sponsor
Medical College of Wisconsin
Enrollment
50 participants
Start Date
Jan 4, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy language functions.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria10
- Healthy Controls
- years of age or older
- Fluent in English
- No history of neurological or psychiatric disorders
- Stroke Patients
- Diagnosed with post-stroke aphasia by referring physician/neuropsychologist
- Consent date \>=1 months after stroke onset
- Right-handed
- Fluent in English
- years of age or older
Exclusion Criteria8
- Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
- Presence of major untreated or unstable psychiatric disease
- A chronic medical condition that is not treated or is unstable
- The presence of cardiac stimulators or pacemakers
- Any metal implants in the skull
- Contraindications to MRI or tACS
- History of seizures
- History of dyslexia or other developmental learning disabilities
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEtACS
Active or Sham tACS will be applied.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04375722
Related Trials
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
NCT066159731 location
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
NCT034017621 location
Strategy Training for Optimizing Attention for Individuals With Spatial Neglect
NCT073318961 location
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
NCT0640296811 locations
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT0506521663 locations